Ligand validation:4HRQ

AZG: 5-AMINO-1H-[1,2,3]TRIAZOLO[4,5-D]PYRIMIDIN-7-OL

AZG is a Ligand Of Interest in 4HRQ designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
4HRQ_AZG_A_201	21%	3%	0.251	0.863	2.5	3.48	2	3	0	0	100%	1
4HRQ_AZG_B_201	19%	3%	0.204	0.796	2.47	3.41	3	4	2	0	100%	1
7C3U_AZG_A_202	95%	18%	0.069	0.972	0.66	2.83	-	6	0	0	100%	1
7C3S_AZG_B_202	57%	7%	0.129	0.902	1.59	3.21	2	5	2	0	100%	0.9182
7C3T_AZG_B_202	43%	11%	0.155	0.878	1.57	2.56	2	4	0	0	100%	1
4HRW_AZG_B_202	39%	4%	0.19	0.898	2.38	3.44	3	4	4	0	100%	1
1V41_AZG_E_290	62%	9%	0.153	0.946	1.68	2.68	2	3	6	0	100%	1
8XZQ_AZG_A_101	54%	22%	0.173	0.939	0.98	2.22	-	3	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.